ERBB2 and breast carcinoma: rs34404564 polymorphism show protective effect in breast cancer patient at AG and GG+AG genotype, it also shows decreased risk in age > 48 at AG; GG; GG+AG genotype and G allele, HER2 negative at AG genotype, HER2 positive, ER positive and PR positive at AG and GG+AG genotype.